SBI Securities’s Quoin Pharmaceuticals QNRX Stock Holding History

SBI Securities’s Portfolio QNRX Stock Details QNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.72K	Buy	355 +353	+17,650%	+$1.91K	﹤0.01%	2604
2026 Q1	$13	Sell	2 -245	-99%	-$2.22K	﹤0.01%	3820
2025 Q4	$3.56K	Buy	247 +245	+12,250%	+$3.33K	﹤0.01%	2163
2025 Q3	$14	Hold	2	–	–	﹤0.01%	3982
2025 Q2	$18	Sell	2 -1	-33%	-$8	﹤0.01%	3933
2025 Q1	$24	Buy	3 +2	+200%	+$26	﹤0.01%	3819
2024 Q4	$16	Buy	+1	New	+$23	﹤0.01%	3875

Other funds holding QNRX

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

SBI Securities's QNRX Position: Q2 2026 in Review

SBI Securities increased its Quoin Pharmaceuticals (QNRX) stake by 17,650% in Q2 2026, buying an estimated $1.91K and bringing the position to 355 shares worth $1.72K. The position accounts for ﹤0.01% of the portfolio, ranked #2604.

SBI Securities first reported a position in QNRX in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.56K in Q4 2025. 2 funds tracked by Wall St. Rank hold QNRX as of Q2 2026.

SBI Securities held 355 shares of Quoin Pharmaceuticals worth $1.72K as of Q2 2026.
SBI Securities bought 353 Quoin Pharmaceuticals shares in Q2 2026, an estimated $1.91K.
Quoin Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2604 holding.
SBI Securities first reported a position in Quoin Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
SBI Securities's Quoin Pharmaceuticals position peaked at $3.56K in Q4 2025.
2 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.